These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25544376)

  • 41. Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancer.
    Shiota M; Song Y; Takeuchi A; Yokomizo A; Kashiwagi E; Kuroiwa K; Tatsugami K; Uchiumi T; Oda Y; Naito S
    J Urol; 2012 Feb; 187(2):707-14. PubMed ID: 22177207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.
    Chua CW; Chiu YT; Yuen HF; Chan KW; Man K; Wang X; Ling MT; Wong YC
    Clin Cancer Res; 2009 Jul; 15(13):4322-35. PubMed ID: 19509141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines.
    Naramoto H; Uematsu T; Uchihashi T; Doto R; Matsuura T; Usui Y; Uematsu S; Li X; Takahashi M; Yamaoka M; Furusawa K
    Int J Oncol; 2007 Feb; 30(2):393-401. PubMed ID: 17203221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.
    Astanehe A; Finkbeiner MR; Krzywinski M; Fotovati A; Dhillon J; Berquin IM; Mills GB; Marra MA; Dunn SE
    Oncogene; 2012 Oct; 31(41):4434-46. PubMed ID: 22249268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.
    Garrido MF; Martin NJ; Bertrand M; Gaudin C; Commo F; El Kalaany N; Al Nakouzi N; Fazli L; Del Nery E; Camonis J; Perez F; Lerondel S; Le Pape A; Compagno D; Gleave M; Loriot Y; Désaubry L; Vagner S; Fizazi K; Chauchereau A
    Clin Cancer Res; 2019 Jan; 25(2):710-723. PubMed ID: 30322877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance.
    Toner AP; McLaughlin F; Giles FJ; Sullivan FJ; O'Connell E; Carleton LA; Breen L; Dunne G; Gorman AM; Lewis JD; Glynn SA
    Br J Cancer; 2013 Oct; 109(8):2131-41. PubMed ID: 24052043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
    Takeda M; Mizokami A; Mamiya K; Li YQ; Zhang J; Keller ET; Namiki M
    Prostate; 2007 Jun; 67(9):955-67. PubMed ID: 17440963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Molecular genetic mechanisms of drug resistance in prostate cancer].
    Krasnov GS; Dmitriev AA; Sadritdinova AF; Volchenko NN; Slavnova EN; Danilova TV; Snezhkina AV; Melnikova NV; Fedorova MS; Lakunina VA; Belova AA; Nyushko KM; Alekseev BY; Kaprin AD; Kudryavtseva AV
    Mol Biol (Mosk); 2015; 49(5):716-27. PubMed ID: 26510590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overcoming paclitaxel resistance in uterine endometrial cancer using a COX-2 inhibitor.
    Hasegawa K; Ishikawa K; Kawai S; Torii Y; Kawamura K; Kato R; Tsukada K; Udagawa Y
    Oncol Rep; 2013 Dec; 30(6):2937-44. PubMed ID: 24100466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of docetaxel resistance genes in castration-resistant prostate cancer.
    Marín-Aguilera M; Codony-Servat J; Kalko SG; Fernández PL; Bermudo R; Buxo E; Ribal MJ; Gascón P; Mellado B
    Mol Cancer Ther; 2012 Feb; 11(2):329-39. PubMed ID: 22027694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
    Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
    Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
    Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
    Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
    Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH
    Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reverse multidrug resistance in laryngeal cancer cells by knockdown MDR1 gene expression.
    Zhigang H; Qi Z; Jugao F; Xiaohong C; Wei Z; Hong W; Hu H; Na M; Zheng Y; Demin H
    J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):440-8. PubMed ID: 19755084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
    Tsang WP; Kwok TT
    Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells.
    Han CY; Cho KB; Choi HS; Han HK; Kang KW
    Carcinogenesis; 2008 Sep; 29(9):1837-44. PubMed ID: 18390843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surmounting chemoresistance by targeting the Y-box binding protein-1.
    Inoue I; Matsumoto K; Yu Y; Bay BH
    Anat Rec (Hoboken); 2012 Feb; 295(2):215-22. PubMed ID: 22190445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.